Vimarsana
Biggest News Aggregation in the World

Page 2 - Jp 4502 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jp 4502. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jp 4502 Today - Breaking & Trending Today

Takeda Trial for Crohn's Perianal Fistulas Treatment Misses Primary Endpoint - Vimarsana News

Takeda Trial for Crohn's Perianal Fistulas Treatment Misses Primary Endpoint

Takeda said Tuesday its trial of darvadstrocel in the treatment of complex Crohn's Perianal Fistulas didn't meet its primary endpoint based on topline data.

Takeda's dengue vaccine gets WHO group's recommendation - Vimarsana News

Takeda's dengue vaccine gets WHO group's recommendation

American depositary receipts of Takeda Pharmaceutical Co. rose more than 1% in the extended session Tuesday after the Japan-based company said its dengue...

Takeda Pharmaceutical's Dengue Vaccine Recommended by WHO Advisory Group - Vimarsana News

Takeda Pharmaceutical's Dengue Vaccine Recommended by WHO Advisory Group

By Denny Jacob Takeda Pharmaceutical's vaccine to prevent dengue, qdenga, was recommended by a World Health Organization advisory group. The company, which...

Takeda to Voluntarily Withdraw Exkivity Following Talks with FDA - Vimarsana News

Takeda to Voluntarily Withdraw Exkivity Following Talks with FDA

By Denny Jacob Takeda Pharmaceutical plans to voluntarily withdraw exkivity following discussions with the Food and Drug Administration. The company, which...

Takeda Pharmaceutical 1Q Net Profit Missed Y113.53B Expected in Poll of Analysts - Vimarsana News

Takeda Pharmaceutical 1Q Net Profit Missed Y113.53B Expected in Poll of Analysts

By Kosaku Narioka Takeda Pharmaceutical said Thursday that its first-quarter net profit fell 15% from a year earlier despite revenue growth in several key...